Sign In
Buy ZYXI
$0.125
+0 (+0%)
At Close: Mar 20, 2026
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on beh
Zynex, Inc. (ZYXI) Q2 2025 Earnings Call Transcript
08:35pm, Thursday, 31'st Jul 2025
Zynex, Inc. (NASDAQ:ZYXI ) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Greg
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
06:36pm, Thursday, 31'st Jul 2025
Zynex Inc. (ZYXI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to earnings of $0.04 per share a year ago.
Zynex eyes growth revival under new CEO, advances oximeter technology
04:26pm, Thursday, 31'st Jul 2025
Zynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational strea
Zynex Reports Second Quarter 2025 Financial Results
04:01pm, Thursday, 31'st Jul 2025
ENGLEWOOD, Colo. , July 31, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex Sets Second Quarter 2025 Earnings Call
09:15am, Tuesday, 22'nd Jul 2025
ENGLEWOOD, Colo. , July 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain
Zynex: New CEO Steven Dyson shares his vision – ICYMI
08:40am, Saturday, 12'th Jul 2025
Zynex Inc (NASDAQ:ZYXI) earlier this week outlined changes to its leadership as Thomas Sandgaard prepares to move into the chairman role. The company said Steven Dyson will step in as the new chief ex
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on beh
Zynex CEO Thomas Sandgaard discusses leadership transition - ICYMI
08:17am, Saturday, 05'th Jul 2025
Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard talked with Proactive about his decision to step down from his position after nearly three decades leading the medical device company. He described the cha
Tricare Temporary Payment Suspension Update
05:15pm, Wednesday, 02'nd Jul 2025
ENGLEWOOD, Colo. , July 2, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain m
Zynex taps Steve Dyson as chief executive officer
10:17am, Monday, 30'th Jun 2025
Zynex Inc (NASDAQ:ZYXI) has announced the appointment of Steve Dyson as chief executive officer, marking a new chapter for the medical technology company founded in 1996 by its outgoing CEO Thomas San
Zynex Announces Steven Dyson as New CEO
09:15am, Monday, 30'th Jun 2025
ENGLEWOOD, Colo. , June 30, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation,
Zynex awarded UK patent for non-invasive sepsis monitoring technology
10:02am, Wednesday, 25'th Jun 2025
Zynex Inc (NASDAQ:ZYXI) announced that it has been issued a UK patent for its multiparameter, non-invasive sepsis monitor. The company highlighted that its patented technology is designed to continuou
Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis
09:15am, Wednesday, 25'th Jun 2025
ENGLEWOOD, Colo. , June 25, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain
